Concepedia

M. Riudavets Melià

MR

Statistics

Publications

2

Citations

36

H-Index

2

Active since

2022

Affiliations

Hospital de Sant Pau(Current)

M. Riudavets Melià is an author at Hospital de Sant Pau specializing in immunotherapy, oncology, and immune checkpoint inhibitors.

Publications per year

2022–2022

2

Publications

2

The integration of systemic and tumor PD-L1 as a predictive biomarker of clinical outcomes in patients with advanced NSCLC treated with PD-(L)1blockade agents

Carlos Zamora, Geòrgia Anguera, M. Riudavets Melià et al. · Cancer Immunology Immunotherapy · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Association between Changes in the Patterns of Antinuclear Autoantibodies during Immune Checkpoint Inhibition Therapy and the Development of Severe Immune Related Adverse Events

Letícia Alserawan, Geòrgia Anguera, Carlos Zamora et al. · International Journal of Molecular Sciences · 2022 · 15 citations · Full text

Life Sciences, Immunology, Oncology +17

1–2 of 2